相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Rapamycin and abundant TCR stimulation are required for the generation of stable human induced regulatory T cells
Juewan Kim et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)
HLA-Class II Artificial Antigen Presenting Cells in CD4+ T Cell-Based Immunotherapy
Alexandre Couture et al.
FRONTIERS IN IMMUNOLOGY (2019)
Rebalancing Immune Homeostasis to Treat Autoimmune Diseases
David A. Horwitz et al.
TRENDS IN IMMUNOLOGY (2019)
Identification and functional characterization of CD8+ T regulatory cells in type 1 diabetes patients
Marsha Pellegrino et al.
PLOS ONE (2019)
Suppression of Murine Lupus by CD4+and CD8+Treg Cells Induced by T Cell-Targeted Nanoparticles Loaded With Interleukin-2 and Transforming Growth Factor β
David A. Horwitz et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Nanoscale artificial antigen presenting cells for cancer immunotherapy
Kelly R. Rhodes et al.
MOLECULAR IMMUNOLOGY (2018)
Simple, Reproducible, and Efficient Clinical Grading System for Murine Models of Acute Graft-versus-Host Disease
Sina Naserian et al.
FRONTIERS IN IMMUNOLOGY (2018)
Good Manufacturing Practice-compliant Production and Lot-Release of Ex Vivo Expanded Regulatory T Cells As Basis for Treatment of Patients With Autoimmune and Inflammatory Disorders
Manuel Wiesinger et al.
FRONTIERS IN IMMUNOLOGY (2017)
Expanding antigen-specific regulatory networks to treat autoimmunity
Xavier Clemente-Casares et al.
NATURE (2016)
Regulatory T Cells in SLE: Biology and Use in Treatment
Sophia Giang et al.
CURRENT RHEUMATOLOGY REPORTS (2016)
Regulatory T-cells in autoimmune diseases: Challenges, controversies and-yet-unanswered questions
Charlotte R. Grant et al.
AUTOIMMUNITY REVIEWS (2015)
Nanoparticle-based autoimmune disease therapy
Pau Serra et al.
CLINICAL IMMUNOLOGY (2015)
Human and mouse CD8(+)CD25(+)FOXP3(+) regulatory T cells at steady state and during interleukin-2 therapy
Guillaume Churlaud et al.
FRONTIERS IN IMMUNOLOGY (2015)
The Suppressive Function of Human CD8+ iTregs is Inhibited by IL-1β and TNFα
U. Bjarnadottir et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2014)
Therapeutic polyclonal human CD8+CD25+Fox3+TNFR2+PD-L1+regulatory cells induced ex-vivo
David A. Horwitz et al.
CLINICAL IMMUNOLOGY (2013)
Robust and cost effective expansion of human regulatory T cells highly functional in a xenograft model of graft-versus-host disease
Rikhia Chakraborty et al.
HAEMATOLOGICA (2013)
Tolerance induced by anti-DNA Ig peptide in (NZB x NZW)F1 lupus mice impinges on the resistance of effector T cells to suppression by regulatory T cells
Yiyun Yu et al.
CLINICAL IMMUNOLOGY (2012)
CD8+ Tregs in lupus, autoimmunity, and beyond
Ravi K. Dinesh et al.
AUTOIMMUNITY REVIEWS (2010)
Artificial Antigen-Presenting Cells for Use in Adoptive Immunotherapy
Cameron J. Turtle et al.
CANCER JOURNAL (2010)
Expansion of FOXP3+ CD8 T Cells with Suppressive Potential in Colorectal Mucosa Following a Pathogenic Simian Immunodeficiency Virus Infection Correlates with Diminished Antiviral T Cell Response and Viral Control
Pragati Nigam et al.
JOURNAL OF IMMUNOLOGY (2010)
Current advances in research and clinical applications of PLGA-based nanotechnology
Jian-Ming Lue et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2009)
Natural Tregs and autoimmunity
Antonio La Cava
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients
Bevra H. Hahn et al.
ARTHRITIS AND RHEUMATISM (2008)
Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion
Petra Hoffmann et al.
BLOOD (2006)
HLA tetramer-based artificial antigen-presenting cells for stimulation of CD4(+) T cells
MV Maus et al.
CLINICAL IMMUNOLOGY (2003)